Nurse prescriber Rebecca Mansell argues that prescribing competence shouldn’t be conflated with competence in independent medical aesthetics practice
Medical aesthetics has experienced rapid growth in the UK, driven by increasing demand for minimally invasive procedures and technological advances.1 The global specialty is estimated to be worth £31.2 billion, with around 900,000 botulinum toxin treatments performed each year.2 Alongside this rapid growth, an increasing number of prescribers are moving into independent aesthetic practice, often at pace.3
A prescribing qualification undoubtedly carries weight. It provides legal authority, pharmacological knowledge and a framework for safe decision making.4 However, aesthetic practice differs from traditional healthcare environments. It is characterised by off-label prescribing, consumer-driven demand and delivery within a largely private sector where governance frameworks can vary.5 In my view, this raises an important and perhaps uncomfortable question: while prescribers are qualified…
